Atlas Trials

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Clinical trial NCT04632199 · WITHDRAWN

Trial details

NCT number
NCT04632199
Sponsor
Ipsen
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Ductal AdenocarcinomaColorectal Cancer
Start date
2021-03-12
Primary completion
2021-12-10
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.